Why the study?
The role of AT1, AT2, and Mas angiotensinergic receptors within the medial amygdaloid nucleus in autonomic, cardiovascular, and baroreflex changes evoked by chronic repeated restraint stress was unknown.
Does acute MeA treatment with angiotensinergic receptor antagonists improve autonomic and cardiovascular changes in rats subjected to chronic stress?
Does acute MeA treatment with angiotensinergic receptor antagonists improve autonomic and cardiovascular changes in rats subjected to chronic stress?
Angiotensinergic receptors in the medial amygdaloid nucleus are involved in the autonomic imbalance evoked by chronic stress in rats, but not in the stress-evoked increase in arterial pressure.
Angiotensin receptor blockade in the MeA attenuates stress-induced cardiac sympathetic activation in rats; hypothesis-generating for human autonomic therapies.
This study investigated the role of AT 1 , AT 2 and Mas angiotensinergic receptors within the MeA in autonomic, cardiovascular and baroreflex changes evoked by a 10‐day (1 hr daily) repeated restraint stress (RRS) protocol. Analysis of cardiovascular function after the end of the RRS protocol indicated increased values of arterial pressure, without heart rate changes. Arterial pressure increase was not affected by acute MeA treatment after the RRS with either the selective AT 1 receptor antagonist losartan, the selective AT 2 receptor antagonist PD123319 or the selective Mas receptor antagonist A‐779. Analysis of heart rate variability indicated that RRS increased the sympathetic tone to the heart, which was inhibited by MeA treatment with either losartan, PD123319 or A‐779. Baroreflex function assessed using the pharmacological approach via intravenous infusion of vasoactive agents revealed a facilitation of tachycardia evoked by blood pressure decrease in chronically stressed animals, which was inhibited by MeA treatment with losartan. Conversely, baroreflex responses during spontaneous fluctuations of blood pressure were impaired by RRS, and this effect was not affected by injection of the angiotensinergic receptor antagonists into the MeA. Altogether, the data reported in the present study suggest an involvement of both angiotensinergic receptors present in the MeA in autonomic imbalance evoked by RRS, as well as an involvement of MeA AT 1 receptor in the enhanced baroreflex responses during full range of blood pressure changes. Results also indicate that RRS‐evoked increase in arterial pressure and impairment of baroreflex responses during spontaneous variations of arterial pressure are independent of MeA angiotensinergic receptors.
No takes yet. Share an insight, caveat, or question.
Costa‐Ferreira et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: